Premium
LeonaBio Inc (LONA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | Dr. Mark J. LittonPresident, CEO & Director | 17,10k | 0,00 | Derivative Exercise and Retained Stock | - | 59,89k | 39,95% |
| 2026-03-03 | Dr. Mark J. LittonPresident, CEO & Director | -5,16k | 27,69k | Derivative Exercise and Sale | 5,37 | 59,89k | - |
| 2026-03-03 | Mr. Robert RenningerCFO | 2,99k | 0,00 | Derivative Exercise and Retained Stock | - | 15,85k | 23,29% |
| 2026-03-03 | Mr. Robert RenningerCFO | -906,00 | 4,87k | Derivative Exercise and Sale | 5,37 | 15,85k | - |
| 2026-03-03 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | 4,40k | 0,00 | Derivative Exercise and Retained Stock | - | 18,38k | 31,46% |
| 2026-03-03 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | -1,33k | 7,13k | Derivative Exercise and Sale | 5,37 | 18,38k | - |
| 2026-03-03 | Dr. Kevin ChurchChief Scientific Officer | 4,50k | 0,00 | Derivative Exercise and Retained Stock | - | 25,18k | 21,74% |
| 2026-03-03 | Dr. Kevin ChurchChief Scientific Officer | -1,36k | 7,30k | Derivative Exercise and Sale | 5,37 | 25,18k | - |
| 2026-03-03 | Dr. Javier San MartinChief Medical Officer | 5,70k | 0,00 | Derivative Exercise and Retained Stock | - | 15,89k | 55,92% |
| 2026-03-03 | Dr. Javier San MartinChief Medical Officer | -1,72k | 9,24k | Derivative Exercise and Sale | 5,37 | 15,89k | - |
| 2025-12-31 | Dr. Javier San MartinChief Medical Officer | 3,02k | 0,00 | Derivative Exercise and Retained Stock | - | 10,19k | 42,19% |
| 2025-12-31 | Dr. Javier San MartinChief Medical Officer | -1,64k | 11,31k | Derivative Exercise and Sale | 6,88 | 10,19k | - |
| 2025-12-31 | Dr. Mark J. LittonPresident, CEO & Director | 8,25k | 0,00 | Derivative Exercise and Retained Stock | - | 42,80k | 23,87% |
| 2025-12-31 | Dr. Mark J. LittonPresident, CEO & Director | -2,59k | 17,79k | Derivative Exercise and Sale | 6,88 | 42,80k | - |
| 2025-12-31 | Mr. Robert RenningerCFO | 939,00 | 0,00 | Derivative Exercise and Retained Stock | - | 12,86k | 7,88% |
| 2025-12-31 | Mr. Robert RenningerCFO | -297,00 | 2,04k | Derivative Exercise and Sale | 6,88 | 12,86k | - |
| 2025-12-31 | Dr. Kevin ChurchChief Scientific Officer | 2,79k | 0,00 | Derivative Exercise and Retained Stock | - | 20,68k | 15,60% |
| 2025-12-31 | Dr. Kevin ChurchChief Scientific Officer | -876,00 | 6,03k | Derivative Exercise and Sale | 6,88 | 20,68k | - |
| 2025-12-31 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | 2,79k | 0,00 | Derivative Exercise and Retained Stock | - | 13,98k | 24,95% |
| 2025-12-31 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | -876,00 | 6,03k | Derivative Exercise and Sale | 6,88 | 13,98k | - |
| 2025-12-18 | Perceptive Advisors LLCSociété | 1,32M | 8,38M | Achat | 6,35 | 1,86M | 244,13% |
| 2025-06-30 | Dr. Kevin ChurchChief Scientific Officer | 2,81k | 0,00 | Derivative Exercise and Retained Stock | - | 16,89k | 19,99% |
| 2025-06-30 | Dr. Kevin ChurchChief Scientific Officer | -852,60 | 2,50k | Derivative Exercise and Sale | 2,94 | 16,89k | - |
| 2025-06-30 | Dr. Mark J. LittonPresident, CEO & Director | 8,32k | 0,00 | Derivative Exercise and Retained Stock | - | 34,55k | 31,73% |
| 2025-06-30 | Dr. Mark J. LittonPresident, CEO & Director | -2,51k | 7,37k | Derivative Exercise and Sale | 2,94 | 34,55k | - |
| 2025-06-30 | Dr. Javier San MartinChief Medical Officer | 3,58k | 0,00 | Derivative Exercise and Retained Stock | - | 7,17k | 99,94% |
| 2025-06-30 | Dr. Javier San MartinChief Medical Officer | -1,08k | 3,18k | Derivative Exercise and Sale | 2,94 | 7,17k | - |
| 2025-06-30 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | 2,81k | 0,00 | Derivative Exercise and Retained Stock | - | 11,19k | 33,60% |
| 2025-06-30 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | -852,60 | 2,50k | Derivative Exercise and Sale | 2,94 | 11,19k | - |
| 2025-06-30 | Mr. Robert RenningerCFO | 946,20 | 0,00 | Derivative Exercise and Retained Stock | - | 10,92k | 9,49% |
| 2025-06-30 | Mr. Robert RenningerCFO | -289,70 | 850,27 | Derivative Exercise and Sale | 2,94 | 10,92k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
